Valuation: Beijing Tong Ren Tang Chinese Medicine Company Limited

Market Cap 4.67B 595M 519M 489M 445M 835M 57.04B 836M 5.86B 2.26B 29.06B 2.24B 2.19B 93.76B P/E 2026 *
10.2x
P/E 2027 * 9x
Enterprise Value 2.18B 278M 242M 228M 208M 390M 26.63B 390M 2.73B 1.05B 13.57B 1.04B 1.02B 43.78B EV / Sales 2026 *
1.47x
EV / Sales 2027 * 1.81x
Free-Float
28.32%
Yield 2026 *
6.81%
Yield 2027 * 7.8%
08-28 Beijing Tong Ren Tang Chinese Medicine Company Limited Reports Earnings Results for the Half Year Ended June 30, 2026 CI
08-28 Beijing Tong Ren Tang Chinese Medicine Company Limited Receives Certificate of Registration of Proprietary Chinese Medicine CI
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-10 Beijing Tong Ren Tang Chinese Medicine Company Limited Approves Special Dividend for the Year Ended 31 December 2025 CI
05-26 Beijing Tong Ren Tang Chinese Medicine Company Limited Receives Certificate of Registration of Proprietary Chinese Medicine CI
05-26 Tong Ren Tang Chinese Medicine Gets Registered to Sell Liver Pacifying Capsules in Hong Kong MT
04-29 Beijing Tong Ren Tang Chinese Medicine Company Limited Proposes Special Dividend for the Year Ended December 31, 2025 CI
04-20 Beijing Tong Ren Tang Chinese Medicine receives certificate of registration of proprietary Chinese medicine RE
03-23 Tong Ren Tang Chinese Medicine's Profit Slides 21% in 2025; Shares Down 5% MT
03-20 Beijing Tong Ren Tang Chinese Medicine Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-20 Beijing Tong Ren Tang Chinese Medicine proposes final dividend HK$0.37 per share RE
03-19 Beijing Tong Ren Tang Chinese Medicine Company Limited announces Annual dividend, payable on June 26, 2026 CI
1 week-4.80%
Current month-5.56%
1 month-10.53%
3 months-15.00%
6 months-32.77%
Current year-35.33%
1 week 0.6
Extreme 0.595
0.61
1 month 0.6
Extreme 0.595
0.68
Current year 0.6
Extreme 0.595
0.96
1 year 0.6
Extreme 0.595
1.01
3 years 0.6
Extreme 0.595
1.58
5 years 0.6
Extreme 0.595
1.89
10 years 0.6
Extreme 0.595
1.89
Manager TitleAgeSince
Chief Executive Officer 51 2024-05-09
Director of Finance/CFO 50 2020-05-20
Director TitleAgeSince
Director/Board Member 54 2013-04-14
Director/Board Member 78 2017-09-11
Director/Board Member 50 2022-08-11
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.80% - - 602M
+1.04%+2.34%+54.91%+111.75% 1,028B
-0.19%+1.18%+52.94%+66.69% 651B
+0.20%+1.04%+18.88%+72.38% 466B
+2.24%+0.94%+37.61%+45.31% 346B
+0.90%+1.95%+18.79%+25.27% 266B
+0.48%+3.34%+11.11%+15.38% 259B
+1.95%+3.06%+37.75%+45.93% 208B
-7.65%-7.28%-33.09%-59.52% 191B
+0.30%+2.83%+31.97%+100.03% 186B
Average +0.02%+2.45%+25.65%+47.02% 400.19B
Weighted average by Cap. +0.56%+2.23%+35.56%+65.31%

Financials

2026 *2027 *
Net sales 1.48B 189M 165M 155M 141M 265M 18.1B 265M 1.86B 716M 9.22B 710M 694M 29.76B 1.66B 211M 184M 173M 158M 296M 20.24B 297M 2.08B 801M 10.31B 794M 776M 33.27B
Net income 457M 58.23M 50.77M 47.82M 43.55M 81.64M 5.58B 81.75M 573M 221M 2.84B 219M 214M 9.17B 518M 66.08M 57.61M 54.26M 49.42M 92.65M 6.33B 92.77M 650M 250M 3.22B 248M 243M 10.41B
Net Debt -2.49B -317M -277M -261M -237M -445M -30.4B -446M -3.12B -1.2B -15.49B -1.19B -1.17B -49.98B -1.68B -214M -186M -175M -160M -299M -20.45B -300M -2.1B -809M -10.42B -802M -784M -33.62B
Logo Beijing Tong Ren Tang Chinese Medicine Company Limited
Beijing Tong Ren Tang Chinese Medicine Co Ltd is an investment holding company principally engaged in the manufacturing and sale of Chinese medicine. The Company operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. It is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
Employees
763
Date Price Change
26-09-21 €0.5950 0.00%
26-09-18 €0.5950 -0.83%
26-09-17 €0.6000 -1.64%
26-09-16 €0.6100 -0.81%
26-09-15 €0.6150 -1.60%
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.580HKD
Average target price
9.750HKD
Spread / Average Target
+74.73%

Annual profits - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!